Tabula Rasa Healthcare to present at HIMSS19
Engineering360 News Desk | February 08, 2019Healthcare technology company Tabula Rasa Healthcare Inc. announced that chairman and CEO Calvin H. 
Knowlton, Ph.D., will present at the Healthcare Information and Management Systems Society (HIMSS) 2019 annual meeting — the leading health information and technology conference — in Orlando.
Dr. Knowlton’s presentation will focus on the expanded use of the company’s proprietary medication risk mitigation technology, MedWise, through its new state-of-the-art SMART on Fast Healthcare Interoperability Resources specification integration. The integration will allow more pharmacists and care providers to access Tabula Rasa HealthCare’s technology directly from their electronic health record (EHR) system, at the point of care. This includes access to MedWise’s simultaneous, accumulative multi-drug interaction assessment that identifies medication-related risk and presents actionable opportunities for clinicians to prevent adverse drug events (ADEs) — the fourth leading cause of death in the U.S. MedWise also produces a medication risk score for each patient that has been shown to correlate directly with medical expenditures: the lower the risk score, the lower the costs.
The presentation will take place on Thursday, Feb. 14 at 10:45 a.m. ET in the Innovation Live Pavilion (Theater 1). At HIMMS19, Tabula Rasa Healthcare will also showcase more of its medication risk management solutions, including the newly-launched version of its medication decision support software, MedWise 2.0, at Kiosk IK39.
MedWise is based on the company’s proprietary technology for predicting safety risk and ADEs associated with polypharmacy. MedWise translates the pharmacokinetics and pharmacodynamics associated with a patient’s medication regimen to formulate meaningful and actionable views of each risk. The technology empowers prescribers to take a more personalized approach to medication management, including medication selection, dosage levels, time-of-day administration and reduction of the total number of medications by eliminating unnecessary prescriptions.
